Three exceptional active investment funds

Actively managed funds can be worth the extra money if they are genuinely active. Matthew Partridge tips three such funds.

As we've mentioned many times before, countless studies show that most fund managers fail to beat the market. That's partly because active managers charge high fees (making it harder to beat the market once fees are accounted for), and partly because so many are closet trackers' funds that hug the index tightly, preferring to underperform the market by a little consistently, rather than take big bets and risk underperforming drastically.

However, it seems that active managers can be worth the money as long as they're genuinely active. Five years ago, Martijn Cremers of the University of Notre Dame and Antti Petajisto of New York University came up with the idea of the active share', a measure of how a portfolio differs from the index.

They found that funds with a high active share (ie, ones that differ greatly from the index) tended to beat both the indexand their less actively managed rivals. It's a finding that has been backed up by other research.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

So where can you find these truly active funds? To be considered highly active', a fund must have an active share of at least 80%. One such fund is the Jupiter European Fund, run by Alexander Darwall. It has an active share of over 90% and focuses on industrials and health care (drug groups Novozymes and Novo Nordisk are its top investments).

It mainly invests in German and Danish stocks, and has beaten the index over three- and five-year periods, returning nearly 120% over the latter period. Small-cap funds also tend to have higher active shares, partly because they have to avoid big blue-chip firms, which make up the biggest part of any index.

The Legal & General UK Alpha Trust focuses on unusual growth and value stocks its largest holding is Aim-listed technology firm, Smart Metering Systems. While this approach has led to a high level of volatility, it has returned more than 135% over the last five years. The annual fee is 1.5%.

Of course, not all large-cap funds are closet trackers. The Martin Currie Global Portfolio Trust (LSE: MNP) is a globally focused investment trust, with an active share of 85%. Manager Tom Walker is bullish on US banks (his top holding is JP Morgan), believing them to be in better condition than their counterparts in Europe.

The fund has beaten its index over one, three and five years. It recently instituted a zero-discount' policy, which aims to buy shares when the discount to net asset value (the underlying value of the portfolio) is greater than 0.5%.The total expense ratio (TER) is 0.84%.

by Matthew Partridge

Dr Matthew Partridge

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.

As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.

Follow Matthew on Twitter: @DrMatthewPartri